Choosing between the two should depend on the drug formulation, dose range, cartridge or container format, target user group, regulatory expectations, cost structure and commercialization plan
More specifically, this helps regulate: Appetite and satiety Food intake and cravings Insulin secretion in response to meals Rate of gastric emptying GLP-1 receptor agonist medications mimic this hormone and act on the brain and gut to reduce hunger, slow digestion, and improve blood sugar management
doi: 10.1111/bph.13139 186 PaouriE.GeorgopoulosS
Well also cover everything you need to know about dosage, supplement types, and potential risks
At the same time, intestinal microbiota dysbiosis leads to decreased levels of immunoglobulin A and G1 (IgA and IgG1) and increased levels of immunoglobulin E (IgE), thereby increasing the risk of developing a variety of diseases (121)